Single high dose of liposomal amphotericin B for histoplasmosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Apr 2023: Trial registered, NCT05814432
  2. 16 Jan 2025: Trial started, NCT05814432

The trials

NCT05814432: Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS

State
Under way
Phase
Phase 3
People
279 planned
Started
16 Jan 2025
Primary completion
1 Jul 2032
Arms
Single high dose arm
Results
None posted
  1. 14 Apr 2023: Trial registered
  2. 16 Jan 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.